
CSANZ - Cardiac Society of Australia & New Zealand
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to CSANZ - Cardiac Society of Australia & New Zealand — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
CSANZ – Cardiac Society of Australia & New Zealand (CSANZ 2026) — 74th Annual Scientific Meeting
Event Snapshot (Confirmed from Official Website)
- Event name: CSANZ 2026 - 74th Annual Scientific Meeting of the Cardiac Society in Sydney, Australia
- Organizer/host (as stated): Hosted by CSANZ New South Wales
- Dates: 6–9 August 2026
- Venue: Sydney International Convention Centre (ICC Sydney)
- City/Country: Sydney, Australia
- Associated meeting (as stated): 50th Annual Scientific Meeting of the International Society for Heart Research (Australasian Section)
What This Event Is (Context)
CSANZ 2026 is the 74th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, held at ICC Sydney from 6–9 August 2026. The scientific program is structured around concurrent sessions and named lectures spanning cardiology themes including imaging, electrophysiology, genetics, heart failure, prevention, basic science, paediatrics, and digital health.
The meeting is led by the scientific program committee (with named convenor/co-convenor and chairs listed on the site) and is positioned as a major cardiology education and research platform across Australasia, with global reach through world-renowned speakers and international research themes.
1) Who Attends (BUYERS / ATTENDEES)
This event is primarily a medical science and clinical research meeting in cardiology. The highest-value “buyer fit” typically comes from organizations and professionals involved in:
- Clinical cardiology and specialist care (cardiologists attending for updates and evidence)
- Cardiology sub-specialties across imaging, electrophysiology, heart failure, prevention, and genetics
- Academic and research stakeholders (basic science and translational researchers)
- Paediatrics and training ecosystems (paediatric cardiology and clinical education)
- Digital health stakeholders (healthtech solutions relevant to cardiology care pathways, monitoring, decision support, and health data)
From an attendee-list/data perspective, the best “buyer” equivalents at a conference like CSANZ are usually those with influence over purchasing, procurement, adoption, clinical evaluation, sites/centres decisions, research partnerships, trial participation, and clinical program rollouts.
Buyer-style titles we typically target for this event type:
- Director / Head of Cardiology (or equivalent)
- Clinical Lead, Electrophysiology
- Clinical Lead, Heart Failure
- Imaging Department Lead (Cardiac Imaging)
- Medical Director, Cardiology Services
- Research Director / Principal Investigator (cardiology)
- Head of Clinical Trials (cardiology / cardiovascular)
- Digital Health Lead / Program Manager (cardiology)
- Procurement Lead (Healthcare) / Category Manager (Medical Devices & Diagnostics)
- Hospital/Health Network Procurement & Contracting stakeholders
2) Where the Show Is Happening + Attendee Geographic Origin
Where: Sydney International Convention Centre (ICC Sydney), Sydney, Australia.
Attendee geographic origin: The official website text provided confirms the venue and meeting scope, but it does not explicitly state attendee country mix or regional origin breakdown. We recommend confirming this via post-event reporting, registration summaries, or organizer communications.
What we can reliably infer from the event’s identity:
- Strong attendance from Australia and New Zealand due to the CSANZ organizational scope
- Participation from wider Australasian cardiology research and specialist networks due to the associated International Society for Heart Research (Australasian Section)
- Evidence of broader visibility through “world-renowned speakers,” but the official text does not provide an explicit attendee geography statistic
3) Audience Reach (Local / National / Global)
The official site text provided does not explicitly label “local vs national vs global” reach in those exact terms. However, CSANZ 2026 is designed as a major annual scientific meeting with concurrent sessions across many cardiology themes and an associated international heart research meeting.
Practical reach classification (recommended positioning for buyer targeting):
- National + Australasian core (Australia/New Zealand primary base)
- International professional visibility through named lectures and international speaker participation
We can refine this to “Local/National/Global” precisely once we receive either (a) organizer audience demographics, or (b) your required target geography priorities for the buyer list.
4) Sample Buyer Company Names (BUYERS ONLY) + Websites
Below are buyer-style company examples that commonly engage with major cardiology scientific meetings through clinical adoption, education, research collaboration, imaging/cardiac electrophysiology equipment, heart failure management solutions, and digital health platforms. We are providing these as starting points to help us build a buyer-relevant list for CSANZ 2026.
Important note: Final buyer accuracy depends on what your client sells (devices, diagnostics, pharma, digital tools, services, training, etc.). We will confirm the best-fit segments once you share your product/service website.
Sample Buyer List (15–20 rows)
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | GE HealthCare | https://www.gehealthcare.com/ | Cardiology Product Manager / Imaging Solutions Manager | Cardiac imaging ecosystem relevance (echo, MRI/CT-related workflows, clinical decision support) aligns with CSANZ imaging streams. |
| 2 | Siemens Healthineers | https://www.siemens-healthineers.com/ | Cardiology Business Unit Manager / Imaging Sales Director | Strong footprint in advanced imaging and diagnostic workflows that support cardiology programs and research adoption. |
| 3 | Philips | https://www.philips.com/ | Cardiology Solutions Manager / Digital Health Program Lead | Digital health and clinical imaging relevance to cardiology care pathways, especially for digital health and imaging themes. |
| 4 | Roche Diagnostics | https://diagnostics.roche.com/ | Cardiovascular Diagnostics Marketing Director / Clinical Specialist | Cardiovascular diagnostics demand intersects with prevention, heart failure, and clinical research pathways. |
| 5 | Abbott | https://www.abbott.com/ | Cardiovascular Marketing Manager / Strategic Partnerships Lead | Cardiovascular solutions and clinical partnerships frequently align with electrophysiology and heart failure care. |
| 6 | Medtronic | https://www.medtronic.com/ | Electrophysiology (EP) Clinical Specialist / Therapy Area Director | Electrophysiology and cardiac rhythm management fit directly with EP-focused sessions and buyer interest in adoption. |
| 7 | Boston Scientific | https://www.bostonscientific.com/ | Cardiovascular Solutions Manager / EP & Interventions Sales Director | Strong relevance to cardiovascular interventions and technology used in research and clinical practice. |
| 8 | Edwards Lifesciences | https://www.edwards.com/ | Cardiac Valve Therapy Manager / Clinical Evidence & Access Lead | Heart failure and cardiovascular outcomes are closely tied to clinical evidence and technology adoption. |
| 9 | Johnson & Johnson (Janssen) | https://www.janssen.com/ | Cardiovascular Medical Affairs Director / Clinical Trial Partnerships Lead | Cardiology medical education and cardiovascular pipeline development commonly connect with major scientific meetings. |
| 10 | AstraZeneca | https://www.astrazeneca.com/ | Cardiovascular Medical Affairs / Clinical Development Manager | Prevention, heart failure, and genetics themes align with cardiovascular clinical programs and evidence-generation. |
| 11 | Novartis | https://www.novartis.com/ | CV Medical Science Liaison (MSL) Manager / Evidence Strategy Lead | Evidence and clinical engagement themes align with international scientific meeting attendance. |
| 12 | Pfizer | https://www.pfizer.com/ | Cardiovascular Medical Affairs Lead / Clinical Trials Director | Cardiology-focused medical engagement supports trial networks and clinical evaluation discussions. |
| 13 | Bio-Rad Laboratories | https://www.bio-rad.com/ | Genomics/Basic Science Sales Lead / Life Science Research Partnerships | Genetics and basic science content creates natural demand for research tools and collaboration. |
| 14 | Hillrom (Getinge) | https://www.hillrom.com/ | Cardiology Care Program Manager / Clinical Solutions Lead | Clinical workflow and patient care systems can map to hospital decision-makers attending cardiology events. |
| 15 | HeartFlow | https://www.heartflow.com/ | Clinical Partnerships Manager / Evidence & Outcomes Lead | Precision imaging and computational cardiology strongly match imaging streams and evidence-driven adoption. |
| 16 | AliveCor (Cadence Heart) / similar digital ECG ecosystems | https://www.alivecor.com/ | Digital Health Partnerships Manager / Clinical Evaluation Lead | Digital health themes at CSANZ create buyer fit for remote monitoring, ECG-enabled programs, and clinical pilots. |
| 17 | Epic Systems (healthcare software) | https://www.epic.com/ | Cardiology Informatics Director / Healthcare IT Partnerships Lead | Digital health and data-driven cardiology care pathways can align with clinical informatics and adoption stakeholders. |
| 18 | Synapse Biomedical (or ECG AI category vendors) | https://www.synapse-biomedical.com/ | Clinical Program Manager / Partnerships & Research Lead | Supports AI-enabled cardiovascular analytics that typically align with prevention and digital health sessions. |
| 19 | Cardiovascular CROs (e.g., ICON) | https://www.iconplc.com/ | Cardiovascular Clinical Trials Director / APAC Partnerships Manager | Trials and research coordination often align with cardiology meeting networks and multi-site studies. |
| 20 | IQVIA | https://www.iqvia.com/ | Healthcare Analytics Director (CV) / Market Access & Real-World Evidence Lead | Real-world evidence and analytics support prevention, heart failure, and healthcare program evaluation. |
5) Job Profiles, Industries & Event Type
Event type (what CSANZ 2026 is “in the market”)
- Medical / Healthcare Scientific Conference
- Cardiology specialty meeting
- Research and clinical education program
- Digital health + translational medicine themes
Job profiles to target (high-fit “buyer” roles)
- Medical Directors (Cardiology / Cardiovascular Services)
- Specialty Clinical Leads (Heart Failure, Electrophysiology, Imaging)
- Research Directors / Principal Investigators
- Clinical Trials Leadership (Director of Trials, Clinical Operations)
- Medical Affairs (Cardiovascular medical affairs leads)
- Health Data / Digital Health Leads (Digital Health Program Manager, Informatics)
- Healthcare Procurement (Category Manager, Contracts, Procurement Lead—medical devices/diagnostics, if relevant to your client)
- Clinical Education Leaders (if your client offers training, professional education, or decision support)
Industries to target (mapped to your provided Apollo-style industry list)
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Health, Wellness & Fitness (only if your client is in wellness/rehab or preventive programs)
- Information Technology & Services (for digital health, analytics, clinical software)
- Computer Software (for platforms used in cardiology workflows)
- Research (labs, translational research tooling, CROs)
- Marketing & Advertising (if your client provides healthcare marketing services, event sponsorship activation, or congress marketing)
- Events Services (only if relevant to your client’s event support/medical congress services)
6) Estimated Attendance (Expected Total Footfall)
Estimated attendance: The official website text provided does not state an expected total footfall figure. We will need your confirmation from additional organizer materials (e.g., media kit, post-event report, or registration statistics) to fill this accurately.
7) Key Focus Areas & Buyer Engagement
Confirmed scientific themes from the official site:
- Imaging
- Electrophysiology
- Genetics
- Heart failure
- Prevention
- Basic science
- Paediatrics
- Digital health
How buyers engage in a meeting like CSANZ 2026 (practical buyer-aligned angles):
- Clinical evidence & adoption: engaging medical directors and clinical leads around outcomes, guidelines, and implementation pathways
- Technology demonstration & workflow integration: imaging and electrophysiology solution providers aligning with how clinicians use tools in real settings
- Research collaboration: genetics and basic science stakeholders seeking partnerships, trials, and research tools
- Prevention programs: stakeholders interested in risk stratification, screening, and longitudinal care models
- Digital health pilots: digital health teams engaging with informatics and clinical program leaders
- Paediatric cardiology focus: pediatric cardiology centers and specialty teams evaluating tools and clinical pathways
8) Client Product Fit — We need your website to identify the best buyers
We can strongly improve buyer targeting for CSANZ 2026 if you share your client’s website (and ideally a one-paragraph description of what they sell).
Please send:
- Client website URL
- What product/service category it belongs to (e.g., cardiac imaging hardware, EP devices, diagnostics, pharma, digital monitoring platform, clinical data/analytics, training, CRO/service)
- Whether they sell into hospitals, research labs, health networks, or clinics
- Target countries/regions (Australia only vs Australia + New Zealand vs broader APAC)
Once we have that, we will prioritize the most relevant buyer segments and produce a focused target list (titles + industries + company patterns) aligned to CSANZ 2026’s streams.
For transparency, here is how we will decide “best buyers” once your product is reviewed:
- If your client sells medical devices (imaging/EP/heart failure tools), we will prioritize device therapy-area managers, clinical specialists, medical directors, and healthcare procurement/category roles.
- If your client sells diagnostics, we will prioritize cardiovascular diagnostics stakeholders, clinical labs, and medical affairs/research leaders.
- If your client sells pharma/biotech, we will prioritize cardiovascular medical affairs and clinical development/trials stakeholders.
- If your client sells digital health, we will prioritize informatics, digital health program leaders, clinical operations, and analytics/evidence roles.
- If your client provides research services or CRO support, we will prioritize trial leadership, research directors, and evidence/real-world evidence stakeholders.
9) Final Recommendation (Buyer List Selling Suitability)
CSANZ 2026 is a high-relevance fit for a buyer-intent audience because the program is structured around major cardiology themes (imaging, electrophysiology, genetics, heart failure, prevention, paediatrics, digital health). That means buyer interest is not generic—buyers naturally map to defined clinical streams and departmental buying/adoption areas.
What we recommend we emphasize to maximize buyer quality:
- Segment by cardiology sub-specialty (Imaging vs EP vs Heart Failure vs Prevention vs Genetics)
- Segment by digital health & informatics if your client is software/platform/data-related
- Ensure we focus on decision-influence roles (medical directors, specialty leads, clinical trials leadership, procurement/category where applicable)
- Target appropriate industries from your provided list (Hospital & Health Care, Medical Devices, Pharmaceuticals, Biotech, Research, IT/Software for digital health)
Next Step (Required from You)
Please share the client website so we can:
- Review the product/service fit against CSANZ 2026 themes
- Shortlist the best buyer companies and the best titles to target
- Deliver a prioritized buyer list that matches your client’s exact go-to-market needs
Data sheet
| Event Name | CSANZ - Cardiac Society of Australia & New Zealand 2026 Annual Scientific Meeting |
| Event Date | 6–9 August 2026 |
| Event Status | Upcoming |
| Venue | ICC Sydney (Sydney International Convention Centre) |
| City | Sydney |
| State / Region | New South Wales |
| Country | Australia |
| Organizer | Cardiac Society of Australia and New Zealand (CSANZ); conference managed by The Conference Company |
| Official Event Website | csanzasm.com |
| Event Type | Annual scientific meeting / medical congress |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | National with international specialist participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Moderate for event identity, dates, and venue; low for headcount because no current attendance number is publicly confirmed. |
| Main Purpose of Event | To convene cardiology and cardiovascular research professionals for scientific education, clinical updates, research presentation, professional networking, and industry engagement. |
CSANZ 2026 is the 74th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, co-located with the 50th Annual Scientific Meeting of the International Society for Heart Research (Australasian Section). The event is scheduled for ICC Sydney from 6–9 August 2026 and is positioned as a major cardiology and cardiovascular science forum in the Australasian healthcare calendar.
The meeting is relevant for clinicians, researchers, hospital decision-makers, device and diagnostics suppliers, pharmaceutical stakeholders, and healthcare innovators. Its program spans cardiology themes such as imaging, electrophysiology, genetics, heart failure, prevention, basic science, paediatrics, and digital health, making it a strong venue for education, product awareness, research partnerships, and specialist buyer engagement.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hospital cardiology leaders | Public and private hospitals, cardiac units, tertiary referral centers | Clinical purchasing influence, product evaluation, pathway adoption | High-value audience for devices, diagnostics, monitoring, and service solutions |
| Interventional cardiologists / electrophysiologists | Specialist clinics, hospitals, academic medical centers | Clinical evaluator, specifier, champion user | Relevant for catheters, implants, imaging, EP systems, consumables |
| Cardiac surgeons | Hospitals, surgical groups, research institutions | Clinical preference, procedure adoption, committee input | Key for surgical devices, biologics, grafts, monitoring, digital tools |
| Nurse unit managers / cardiac nurse leaders | Cardiac wards, ICU, ED, outpatient programs | Workflow adoption, purchasing feedback, implementation influence | Important for monitoring, education, patient management, training |
| Hospital procurement and supply chain teams | Hospital procurement, sourcing, supply chain, category management | Budget control, vendor selection, contract negotiation | Direct buyer relevance for devices, consumables, IT, and services |
| Researchers and academics | Universities, institutes, research hospitals | Protocol selection, trial collaboration, grant and publication influence | Relevant for research tools, trial services, data platforms, lab equipment |
| Digital health / health IT leaders | Health systems, digital health firms, telehealth providers | Technology selection, integration, deployment influence | Relevant for EHR, remote monitoring, analytics, AI, interoperability |
| Pharma and medtech commercial teams | Pharmaceuticals, medical devices, diagnostics companies | Partnerships, sponsorship, market access, education support | Relevant for brand building, scientific exchange, and lead generation |
| Public health and policy stakeholders | Government health agencies, guideline groups, advisory bodies | Policy influence, funding, procurement and program design | Relevant for population health, prevention, and system-level solutions |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Sydney / Greater Sydney | High | High | Largest local base of hospitals, specialists, universities, and health vendors. |
| New South Wales | High | High | Strong state-wide clinical and procurement participation expected. |
| Melbourne / Victoria | Medium-High | High | Major tertiary hospital and medtech cluster; strong inter-state attendance likely. |
| Brisbane / Queensland | Medium | Medium-High | Likely participation from specialist centers and health networks. |
| Adelaide / South Australia; Perth / Western Australia; Canberra / ACT | Medium | Medium | Smaller but important specialist and public-sector health participation. |
| New Zealand | Medium | Medium | Cross-Tasman relevance is strong due to CSANZ’s binational membership. |
| Asia-Pacific / international specialist markets | Low-Medium | Medium | Primarily for scientific speakers, industry sponsors, and niche research collaboration. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The meeting is centered on Australia and New Zealand’s cardiology community and is expected to draw participants from across Australia. |
| Global | Secondary reach | International speakers, researchers, sponsors, and specialist collaborators may participate, but the core audience remains Australasian. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NSW Health | Government / healthcare buyer | Major public hospital and procurement ecosystem for cardiac services | nsw.gov.au | Procurement Manager, Clinical Director, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| NSW Agency for Clinical Innovation | Government / health system improvement | Influences clinical redesign, care pathways, and innovation adoption | aci.health.nsw.gov.au | Program Manager, Clinical Lead, Improvement Director | Strong Market Fit, Attendance Not Confirmed |
| Sydney Local Health District | Public hospital network | Large tertiary network with relevant cardiology and procurement stakeholders | sydneyhealth.org.au | Cardiology Director, Procurement Manager, Nursing Unit Manager | Strong Market Fit, Attendance Not Confirmed |
| Monash Health | Hospital network | Large Victorian health system with specialist cardiac services | monashhealth.org | Director of Cardiology, Supply Chain Manager, CIO | Strong Market Fit, Attendance Not Confirmed |
| Austin Health | Hospital network | Known for specialist tertiary care and research participation | austin.org.au | Clinical Director, Research Manager, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Royal Prince Alfred Hospital | Public hospital | Major Sydney tertiary hospital with relevant specialist teams | slhd.nsw.gov.au/rpa | Head of Cardiology, Facilities Director, Procurement Officer | Strong Market Fit, Attendance Not Confirmed |
| St Vincent’s Hospital Sydney | Hospital / research center | Cardiology, research, and innovation decision-makers likely to attend scientific meetings | svhs.org.au | Cardiology Lead, Research Director, Innovations Manager | Strong Market Fit, Attendance Not Confirmed |
| The Alfred | Hospital network | Major Melbourne cardiac and intensive care center | alfredhealth.org.au | Clinical Director, Operations Manager, Biomedical Engineering Manager | Strong Market Fit, Attendance Not Confirmed |
| Mater Health | Hospital / health system | Large health provider with specialist cardiac and research presence | mater.org.au | Cardiology Manager, Procurement Director, Digital Health Lead | Strong Market Fit, Attendance Not Confirmed |
| Royal Brisbane and Women's Hospital | Public hospital | Large tertiary hospital with relevant cardiology leadership | health.qld.gov.au | Cardiology Head, Supply Manager, Department Director | Strong Market Fit, Attendance Not Confirmed |
| Alfred Health | Hospital network | Cardiac care, ICU, and innovation buying influence | alfredhealth.org.au | Procurement Manager, Cardiac Services Director, IT Director | Strong Market Fit, Attendance Not Confirmed |
| Baker Heart and Diabetes Institute | Research institute | Research collaborations, clinical innovation, and scientific sponsorship relevance | baker.edu.au | Research Director, Principal Investigator, Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| University of Sydney | University / research | Cardiovascular research and translational science stakeholders | sydney.edu.au | Professor, Research Manager, Clinical Trials Lead | Strong Market Fit, Attendance Not Confirmed |
| University of Melbourne | University / research | Strong academic cardiology and research buyer profile | unimelb.edu.au | Department Chair, Research Fellow, Grants Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Medical Director | Executive / Clinical Leadership | C-Level / VP | Influences clinical strategy, vendor approval, and major adoption decisions. |
| 2 | Director of Cardiology / Head of Cardiology | Cardiology | Director | Primary specialist buyer and influencer for cardiology products and services. |
| 3 | Interventional Cardiologist | Clinical | Senior / Lead Physician | Key evaluator for devices, clinical systems, and evidence-driven solutions. |
| 4 | Electrophysiologist | Clinical | Senior / Lead Physician | High relevance for ablation, EP lab, mapping, monitoring, and workflow tech. |
| 5 | Cardiac Surgeon | Clinical | Senior / Lead Physician | Influences surgical product evaluation and operating room adoption. |
| 6 | Procurement Manager / Category Manager | Procurement / Supply Chain | Manager / Senior Manager | Direct buyer for devices, consumables, services, and contracts. |
| 7 | Nursing Unit Manager / Nurse Manager | Nursing / Operations | Manager | Influences workflow, training, and product implementation. |
| 8 | Director of Digital Health / Health IT Manager | IT / Digital Health | Director / Manager | Relevant for connected devices, interoperability, analytics, and remote monitoring. |
| 9 | Research Director / Clinical Trials Manager | Research / Innovation | Director / Manager | Important for trials, data services, and scientific collaborations. |
| 10 | Biomedical Engineering Manager | Engineering / Operations | Manager | Evaluates device performance, maintenance, and technical support needs. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core audience is hospital-based cardiology and clinical care | Clinical leaders, procurement, operations, nursing |
| 2 | Medical Devices | Strong alignment with cardiology device suppliers and buyers | Interventional, surgical, diagnostic, monitoring products |
| 3 | Pharmaceuticals | Relevant for prevention, heart failure, lipid, and cardiometabolic therapies | Medical affairs, brand, market access, education sponsorship |
| 4 | Biotechnology | Research and translational medicine overlap strongly with cardiology science | Clinical research, biomarker, and trial partnerships |
| 5 | Information Technology & Services | Digital health, remote monitoring, and interoperability are featured themes | Health IT, analytics, integration, patient engagement tools |
| 6 | Research | Scientific congress environment attracts researchers and trial teams | Data platforms, trial services, lab support, research collaboration |
| 7 | Government Administration | Public health and hospital system stakeholders may attend | Policy, procurement, and health system transformation |
| 8 | Management Consulting | Healthcare strategy and transformation firms often support provider networks | Advisory, change management, service redesign |
| 9 | Higher Education | Academic cardiology and research institutions are core participants | Professor, research, and clinical trial engagement |
| 10 | Environmental Services | Hospital operations increasingly include sustainability and compliance considerations | Facility services, waste management, sustainability solutions |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official event website reviewed | No organizer-published attendance count found in supplied official content. |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | Official event website reviewed | Exhibitor list page referenced, but count not stated in supplied content. |
| Buyer count | Not publicly confirmed | Estimated only | Based on event type and audience mix | Buyer-side participation likely concentrated among hospital, clinical, procurement, and research stakeholders. |
| Speaker count | Not publicly confirmed in supplied content | Confirmed unavailable | Official website references speakers page | Named speakers are listed on the site, but total count is not stated in the provided text. |
| Historical attendance | Not verified from supplied content | Unavailable | No prior-year count provided | Use prior-year official materials only if a future attendance estimate is needed for outbound targeting. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Cardiovascular devices | Clinical performance, safety, and procedural outcomes | Hands-on demonstrations and KOL-led conversations | Interventional, surgical, and monitoring devices |
| Digital health | Remote care, interoperability, and data capture | Solution briefing with IT and clinical leaders | Remote monitoring, analytics, care coordination software |
| Research and trials | Study support, data quality, and evidence generation | Sponsor and investigator meetings, abstracts, poster sessions | Clinical trial services, data platforms, laboratory support |
| Prevention and chronic disease management | Long-term care improvement and patient engagement | Educational content and program-based outreach | Therapeutics, education platforms, monitoring tools |
| Hospital procurement | Vendor standardization, pricing, and contract value | Targeted meetings with sourcing and category managers | Supply contracts, service bundles, consumables, support |
| Education and professional development | Evidence-based learning and training | Sponsored sessions and faculty engagement | Training services, education grants, content sponsorship |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience is tightly aligned to cardiology, hospital care, research, and medtech procurement. |
| Decision-maker availability | High | Senior clinicians, hospital leaders, and research decision-makers are likely to attend. |
| Data collection potential | Medium | Good for sponsor, speaker, and agenda-based profiling; limited public attendee count data. |
| Apollo targeting potential | Very High | Strong fit for Apollo industries, seniority filters, and cardiology-related titles. |
| Geographic targeting potential | High | Excellent ability to target Australia, New Zealand, and key hospital hubs. |
| Best outreach approach | High-touch, account-based outreach | Best results will come from targeted pre-event email, LinkedIn, and meeting-request campaigns. |
| Overall lead quality | High | Scientific meeting with strong buyer overlap in hospitals, research, devices, and digital health. |
| Best use case | B2B attendee list building and account-based prospecting | Useful for supplier sales, sponsorship outreach, and specialist healthcare lead generation. |
| Limitations / risks | Moderate | No current public attendee list or attendance figure is confirmed in the provided official content. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Information Technology & Services; Research; Government Administration; Higher Education | Capture the full clinical, commercial, and research buyer universe |
| Departments | Clinical, Procurement, Supply Chain, Operations, IT, Research, Partnerships, Business Development | Focus on decision-making and implementation teams |
| Seniority | Manager, Director, VP, CXO, Head, Principal, Lead | Prioritize senior stakeholders and budget holders |
| Job titles | Cardiology Director, Clinical Director, Procurement Manager, Category Manager, Medical Director, Research Director, Digital Health Lead, Operations Director, Nurse Manager, Biomedical Engineering Manager | Target the most commercially relevant attendee profiles |
| Geography | Australia; New Zealand; Sydney; Melbourne; Brisbane; Perth; Adelaide; Auckland; Wellington | Align outreach to likely attendee catchment and buyer hubs |
| Employee size | 51-200, 201-500, 501-1,000, 1,001-5,000, 5,001+ | Covers hospitals, medtech, pharma, research institutes, and enterprise healthcare providers |
| Keywords | cardiology, cardiovascular, heart failure, electrophysiology, imaging, digital health, remote monitoring, clinical trials, interventional, hospital procurement | Refine to roles and organizations most likely to engage at the event |
| Company type | Healthcare provider, hospital network, research institute, university, medtech, pharma, government agency | Prioritize true buyers and stakeholders, not just exhibitors |
Suggested Apollo Search Logic: (“cardiology” OR “cardiovascular” OR “heart failure” OR “electrophysiology” OR “digital health”) AND (hospital OR health care OR medical devices OR pharmaceuticals OR biotechnology) AND (Director OR Head OR Manager OR VP OR CMO OR Clinical Director OR Procurement Manager) AND (Australia OR New Zealand).
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| CSANZ 2026 Official Event Website | Primary official source | Event name, date, venue, city, country, organizer context, program themes, key dates, and event positioning | Very High |
| ICC Sydney Official Website | Venue source | Venue identity and location validation | High |
| Cardiac Society of Australia and New Zealand (CSANZ) | Organizer / association source | Organizer identity and association relevance to cardiology audience | High |
| Official event pages referenced in supplied site text: Program, Speakers, Sponsorship, Exhibitors, Abstracts, Key Dates | Official site structure | Confirmed existence of scientific program, speaker, sponsor, exhibitor, and abstract information pages | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to CSANZ - Cardiac Society of Australia & New Zealand — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.